about-me variable
Julius Clinical invites you to their event

Genetic architecture of NAFLD: where do we stand?

About this event

NASH Webinar Series

Webinar 5 - Genetic architecture of NAFLD: where do we stand?

Genome-wide association studies have uncovered robust and reproducible associations between several genetic variations and the natural history of NAFLD. During this webinar, Professor Eric Trépo will review these findings that have provided compelling new insights into the biology of NAFLD and highlighted potentially attractive pharmaceutical targets. Professor Eric Trépo will also discuss potential applications and limitations of genetic variations for risk prediction in this disease

Speaker: Prof. Eric Trépo

Host: Prof. Manuel Castro Cabezas

Co-host: Prof. Christophe Moreno

Audience: Clinicians, researchers, pharmaceutical industry workers, public health workers

----------------------------------------------------------------------------------------

NASH Webinar Series

This webinar is the third webinar of the NASH webinar series, each focusing on recent developments or publications on nonalcoholic steatohepatitis (NASH). The topics and publications are selected by KOLs of NASH Clinical based on relevant ground-breaking NASH research in a high-impact journal. During these webinars we offer you the opportunity to interact with original authors and experts in the NASH field.

Julius Clinical

The Science CRO

Julius Clinical is the Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world.